An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients

Clinical trial NCT02103439 · COMPLETED

Trial details

NCT number: NCT02103439
Sponsor: Biocad
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis Hepatitis C Hepatitis C/ Human Immunodeficiency Virus Coinfection

Start date: 2013-06-06
Primary completion: 2015-08-26
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.